Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.Human Brain Mapping · 2026-06-30A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's DiseaseClinicalTrials.gov · 2026-06-07Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-070408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart StudySLEEP · 2026-04-30Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-12Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22Psilocybin microdosing in the United States: Insights from a nationally representative surveyAddiction · 2026-03-07Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.Unknown journal · 2026-02-23Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscapeAustralian & New Zealand Journal of Psychiatry · 2025-12-16Comparative Efficacy of Psilocybin and MDMA in PTSD Treatment: A Systematic Review of Long-Term OutcomesBerkeley Scientific Journal · 2025-11-12CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-10-31Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-14We need to talk about shrooms.Nordisk alkohol- & narkotikatidskrift: NAT · 2025-05-20Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Unknown journal · 2025-04-21Psilocybin biosynthesis enhancement through gene source optimizationMetabolic Engineering · 2025-04-15Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-03-28Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-02-12The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.Unknown journal · 2024-11-28Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-06Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorderPsychedelics. · 2024-09-23Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Psilocybin-assisted therapy and HIV-related shameScientific Reports · 2024-08-01Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-06-30High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-06-30Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectanciesPsyArXiv · 2024-06-09Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushroomsPsychopharmacology · 2024-04-29Do undergraduates’ views of psychedelics relate to the context for psychedelic use?PsyArXiv · 2024-04-23Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensemblesbioRxiv · 2024-02-03Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2023-12-31IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.Pharmacological research · 2023-12-31Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.Journal of psychoactive drugs · 2023-12-31Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionPsychological Medicine · 2023-06-01Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-24A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapymedRxiv · 2023-04-18347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic DisorderBiological Psychiatry · 2023-04-09Liminal spaces, seasonal faces: Challenging drug market assumptions via an exploration of naturally occurring magic mushroom markets in rural Kent.The International journal on drug policy · 2023-03-31Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorderJournal of Psychiatric Research · 2023-03-27Therapeutic effect of psilocybin in addiction: A systematic review.Unknown journal · 2023-02-08Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-29Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.PLoS ONE · 2022-08-23Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.Unknown journal · 2022-08-10Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity.Frontiers in Psychiatry · 2022-05-17Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.Unknown journal · 2022-01-12The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.Unknown journal · 2021-07-26Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.Unknown journal · 2020-11-29Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyEClinicalMedicine · 2020-09-23Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.Unknown journal · 2019-12-31T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-30Psychedelic use and intimate partner violence: The role of emotion regulation.Journal of Psychopharmacology · 2018-05-28Psilocybin for treating substance use disorders?Unknown journal · 2016-08-11Homological scaffolds of brain functional networks.Journal of The Royal Society Interface · 2014-11-30The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.Frontiers in Human Neuroscience · 2014-02-02Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humansInternational Journal of Psychophysiology · 2008-07-16Effects of psilocybin on time perception and temporal control of behaviour in humans.Queensland's institutional digital repository (The University of Queensland) · 2006-05-18Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.Unknown journal · 2005-05-315-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.Unknown journal · 1999-04-30Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.Unknown journal · 1998-11-30